Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Bank Of America | BAC | Sep 19, 2024 | 40.87 | +3.16 |
Bank Of New York Mellon | BK | Sep 19, 2024 | 71.72 | +0.96 |
Bath & Body Works | BBWI | Sep 19, 2024 | 29.92 | +0.71 |
Baxter International | BAX | Sep 19, 2024 | 38.76 | -1.55 |
Becton, Dickinson And Co | BDX | Sep 19, 2024 | 234.63 | +1.31 |
Berkshire Hathaway B | BRK-B | Sep 19, 2024 | 459.71 | +0.68 |
Best Buy | BBY | Sep 19, 2024 | 98.46 | -0.62 |
Bio-Rad Laboratories A | BIO | Sep 19, 2024 | 344.60 | +1.22 |
Bio-Techne | TECH | Sep 19, 2024 | 80.36 | +5.03 |
Biogen | BIIB | Sep 19, 2024 | 201.44 | +1.95 |
BlackRock | BLK | Sep 19, 2024 | 934.87 | +1.32 |
Blackstone | BX | Sep 19, 2024 | 159.66 | +3.05 |
Boeing | BA | Sep 19, 2024 | 154.59 | -0.34 |
Booking | BKNG | Sep 19, 2024 | 4 017.51 | -0.27 |
BorgWarner | BWA | Sep 19, 2024 | 34.11 | +4.22 |
Boston Properties | BXP | Sep 19, 2024 | 82.31 | +1.25 |
Boston Scientific | BSX | Sep 19, 2024 | 83.71 | +1.38 |
Bristol-Myers Squibb | BMY | Sep 19, 2024 | 49.02 | -1.45 |
Broadcom | AVGO | Sep 19, 2024 | 167.42 | +3.56 |
Broadridge Financial Solutions | BR | Sep 19, 2024 | 208.99 | +0.19 |
Brown & Brown | BRO | Sep 19, 2024 | 101.45 | -1.03 |
Brown Forman B | BF-B | Sep 19, 2024 | 47.76 | +0.15 |
Builders Firstsource | BLDR | Sep 19, 2024 | 201.83 | +3.76 |
Bunge | BG | Sep 19, 2024 | 100.36 | +2.71 |
C.H. Robinson Worldwide | CHRW | Sep 19, 2024 | 103.64 | +1.57 |
Cadence Design Systems | CDNS | Sep 19, 2024 | 280.35 | +3.95 |
Caesars Entertainment | CZR | Sep 19, 2024 | 41.58 | +3.25 |
Camden Property Trust | CPT | Sep 19, 2024 | 126.66 | +1.13 |
Campbell Soup | CPB | Sep 19, 2024 | 50.84 | -0.47 |
Capital One Financial | COF | Sep 19, 2024 | 153.05 | +5.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.